These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36206131)

  • 1. Correlation between the drug concentration of polymyxin B and polymyxin B-associated acute kidney injury in critically ill patients: A prospective study.
    Xu Y; Liang P; Liu N; Dong D; Gu Q; Wang X
    Pharmacol Res Perspect; 2022 Oct; 10(5):e01010. PubMed ID: 36206131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin-B and vancomycin-associated acute kidney injury in critically ill patients.
    Soares DS; Reis ADF; Silva Junior GBD; Leite TT; Parente Filho SLA; Rocha CVO; Daher EF
    Pathog Glob Health; 2017 May; 111(3):137-142. PubMed ID: 28353411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-dosing interval concentration is important for polymyxin B exposure and acute kidney injury in critically ill patients.
    Wang J; Li Y; Huang S; Wang M; Jin L; Luo X; Cheng X; Yang N; Zhu H
    CPT Pharmacometrics Syst Pharmacol; 2023 Dec; 12(12):1911-1921. PubMed ID: 37655610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of risk factors of polymyxin B-associated acute kidney injury in intensive care unit patients with severe infection].
    Wang Y; Chen X; Guo X; Cao K; Zhu Z; Zhang B; Liang P; Yu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):716-720. PubMed ID: 32684219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients.
    Deng Y; Gu JY; Li X; Tong H; Guo SW; Xu B; Li Y; Zhang BK; Li Y; Huang HY; Xiao GY
    Infect Dis Ther; 2022 Aug; 11(4):1591-1608. PubMed ID: 35689791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trough polymyxin B plasma concentration is an independent risk factor for its nephrotoxicity.
    Han L; Xu FM; Zhang XS; Zhang CH; Dai Y; Zhou ZY; Wang YX; Chen F; Shi DW; Lin GY; Yu XB
    Br J Clin Pharmacol; 2022 Mar; 88(3):1202-1210. PubMed ID: 34449094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors for acute kidney injury in patients treated with polymyxin B experience from 139 cases at a tertiary university hospital in Colombia].
    Osorio J; Barreto J; Samboni CF; Cándelo LA; Álvarez LC; Benavidez S; Téllez RP; Santofimio D; Ramos JA; Gómez CA
    Rev Chilena Infectol; 2017 Feb; 34(1):7-13. PubMed ID: 28394975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and nephrotoxicity of polymyxin B in elderly patients with carbapenem resistant bacterial infection.
    Xia GL; Xu X; You XB; Wang X; Feng DD; Lei S; Jiang RL
    Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):101. PubMed ID: 37968642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit.
    Xu Y; Jin L; Liu N; Luo X; Dong D; Tang J; Wang Y; You Y; Liu Y; Chen M; Yu Z; Hao Y; Gu Q
    Int J Infect Dis; 2019 May; 82():79-85. PubMed ID: 30878630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cystatin C versus renal resistive index as early predictors of acute kidney injury in critically ill neonates.
    El-Sadek AE; El-Gamasy MA; Behiry EG; Torky AA; Fathy MA
    J Pediatr Urol; 2020 Apr; 16(2):206.e1-206.e8. PubMed ID: 31926796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.
    Akajagbor DS; Wilson SL; Shere-Wolfe KD; Dakum P; Charurat ME; Gilliam BL
    Clin Infect Dis; 2013 Nov; 57(9):1300-3. PubMed ID: 23840000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study.
    Rigatto MH; Behle TF; Falci DR; Freitas T; Lopes NT; Nunes M; Costa LW; Zavascki AP
    J Antimicrob Chemother; 2015 May; 70(5):1552-7. PubMed ID: 25604744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between postoperative immediate serum albumin level and postoperative acute kidney injury after major abdominal surgery in critically ill patients].
    Li W; Li N; Li S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):955-961. PubMed ID: 34590563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness, nephrotoxicity, and therapeutic drug monitoring of polymyxin B in nosocomial pneumonia among critically ill patients.
    Ye Q; Wang Q; Chen Z; Chen W; Zhan Q; Wang C
    Clin Respir J; 2022 May; 16(5):402-412. PubMed ID: 35586931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for polymyxin B-associated acute kidney injury.
    Chang K; Wang H; Zhao J; Yang X; Wu B; Sun W; Huang M; Cheng Z; Chen H; Song Y; Chen P; Chen X; Gan X; Ma W; Xing L; Wang Y; Cao B
    Int J Infect Dis; 2022 Apr; 117():37-44. PubMed ID: 35108608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
    Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the Population Pharmacokinetics of and Acute Kidney Injury Due to Polymyxin B in Chinese Patients with or without Renal Insufficiency.
    Wang P; Zhang Q; Zhu Z; Pei H; Feng M; Sun T; Yang J; Zhang X
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy.
    Kubin CJ; Ellman TM; Phadke V; Haynes LJ; Calfee DP; Yin MT
    J Infect; 2012 Jul; 65(1):80-7. PubMed ID: 22326553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Acute Kidney Injury in Intermittent Versus Continuous Infusion of Polymyxin B in Hospitalized Patients.
    Alvarado Reyes Y; Cruz R; Gonzalez J; Perez Y; Wolowich WR
    Ann Pharmacother; 2019 Sep; 53(9):886-893. PubMed ID: 30971094
    [No Abstract]   [Full Text] [Related]  

  • 20. Subclinical acute kidney injury is associated with adverse outcomes in critically ill neonates and children.
    Fang F; Hu X; Dai X; Wang S; Bai Z; Chen J; Pan J; Li X; Wang J; Li Y
    Crit Care; 2018 Oct; 22(1):256. PubMed ID: 30305134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.